Thu 17 Mar 2022 09:00-12:50
Online Forum

This online forum has now taken place. Both insightful and interactive, attendees came together at this online forum, with haematology MDTs from across the country to discover what is going on nationally and get themselves and their team up to date. Sponsored by Bristol Myers Squibb, delegates were able to take away important information from leading clinical professionals on the latest developments to put into practice and improve diagnosis, treatment and management of patients.

If you would like to attend a future event on this topic, please email our Customer Service Team or telephone 01732 897 788. They will be happy to assist you.

Latest Developments and Clinical Updates for Haemato-Oncology
Past forum 3 hours
Bristol Myers Squibb

3 hours Continuing Professional Development

This dedicated forum focused on:

  • An overview of CAR T-Cell Therapy: patient suitability, toxicity and referral management and future planning
  • Developing emergency haematological provisions and improving recognition and management of wide ranging emergencies
  • Management considerations for CLL and Multiple Myeloma: latest guidance and research, management considerations and case studies explored
9:30
Introduction, instructions and chair’s opening remarks
Sarah Henshaw, Myeloma Clinical Nurse Specialist, Nursing Lead and Trustee, Nottingham University Hospitals NHS Trust, UK Myeloma Forum and Myeloma UK Board of Directors
Specialist treatment explored
9:40
An overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Understanding patient suitability
  • Guidance for managing toxicities and referrals
  • Future planning: moving toward ambulatory care
Dr Reuben Benjamin, Consultant Haematologist and Honorary Senior Lecturer, King's College Hospital NHS Foundation Trust
Developing emergency provisions
10:10
Triaging, diagnosing and treating haematological emergencies
  • Recognising the signs and symptoms of common and uncommon haematological emergencies
  • Guidance for identifying and managing Tumor Lysis Syndrome (TLS)
  • Determining when cases should be considered emergencies and how to manage those patients
Dr Rebecca Frewin, Consultant Haematologist, Gloucestershire Hospitals NHS Foundation Trust
10:40
Launching the new Haem Now educational website
Sarah Henshaw, Myeloma Clinical Nurse Specialist, Nursing Lead and Trustee, Nottingham University Hospitals NHS Trust, UK Myeloma Forum and Myeloma UK Board of Directors
10:50
Questions and answers with the speakers
11:00
Interactive discussion: Improving MDT collaboration to achieve robust diagnosis and management
Breaking into small groups to discuss and share your experiences on this important topic with your fellow attendees
11:20
Screen break
11:30
Feedback from interactive discussion on Improving MDT collaboration to achieve robust diagnosis and management
Moderators will go on screen to feedback what has been discussed and learnt in the individual breakout rooms. Whilst the presenters are speaking, you can feedback your comments and questions using the chat box function.
Management considerations
11:40
Effective treatments and symptom management for Multiple Myeloma
  • Understanding the latest research, guidelines and management policies
  • Considering all treatment options for newly diagnosed patients
  • Management considerations for new Multiple Myeloma drug treatments
Sarah Henshaw, Myeloma Clinical Nurse Specialist, Nursing Lead and Trustee, Nottingham University Hospitals NHS Trust, UK Myeloma Forum and Myeloma UK Board of Directors
12:10
Enhancing management and treatment of Chronic Lymphocytic Leaukemia (CLL)
  • Latest guidelines and management techniques for CLL diagnosis
  • Exploring developing treatment options and combination therapies
  • Effectively recognising and signposting side effects
Dr Dima El-Sharkawi, Consultant Haematologist, The Royal Marsden NHS Foundation Trust
12:40
Questions and answers with the speakers
12:50
Chair’s closing remarks and close of forum

Benefit from 'real expert' speakers who are leading in their field:


Job Title:
Myeloma Clinical Nurse Specialist, Nursing Lead and Trustee
Organisation
Nottingham University Hospitals NHS Trust, UK Myeloma Forum and Myeloma UK Board of Directors
Biography

Sarah qualified as a nurse in 1997 with a diploma in adult nursing. She has worked in haematology in a small district general hospital and a big teaching hospital since qualification. In 2005 Sarah obtained her BSc (hons) Health Care Studies (Haem-Onc) and has used this to further her career. 

Sarah has experience as a Clinical Nurse Educator in a level 4 haematology Centre and 14 years’ experience as a Myeloma Clinical Nurse Specialist. 

Sarah is a non-medical prescriber, extensively using these skill with independent nurse led clinics that she has set up. Sarah recently obtained MSc Health and Social Care specialised in palliative care with distinction. Her dissertation research for this was “Improving long term quality of life for patients living with multiple myeloma: A service evaluation”.


Job Title:
Consultant Haematologist and Honorary Senior Lecturer
Organisation
King's College Hospital NHS Foundation Trust
Biography

Reuben Benjamin is a Consultant Haematologist and Honorary Senior Lecturer with an interest in multiple myeloma, stem cell transplantation and cell therapy.

He completed his haematology training at University College Hospital, London and then worked as a post doctorate research fellow at Memorial Sloan Kettering Cancer Center, NY undertaking translational research in CAR-T cell therapy for leukaemia and myeloma.

Since 2014 he has been based at King's College Hospital, London where he leads the plasma cell disorder service and CAR-T cell programme. He is Chief Investigator of the CALM Trial, the first allogeneic off-the-shelf CAR-T cell study for relapsed adult B-ALL and is also actively involved in offering CAR-T cell therapy for myeloma and lymphoma.

He has an active research group at King’s College London focusing on allogeneic CAR-T cells for lymphoid malignancies as well as in studying the biology of extramedullary myeloma.


Job Title:
Consultant Haematologist
Organisation
Gloucestershire Hospitals NHS Foundation Trust
Biography

Rebecca Frewin has been a consultant Haematologist since 2004 and is working for Gloucestershire Hospitals NHS Trust. She has a significant clinical interest in Myeloproliferative Neoplasms and CML and is the current chair of the South West MPN Network. She remains active in both post graduate and undergraduate medical education.


Job Title:
Consultant Haematologist
Organisation
The Royal Marsden NHS Foundation Trust
Biography

Dima El-Sharkawi was appointed as a Consultant Haematologist at the Royal Marsden Hospital in 2017. 

She studied medicine at University of Cambridge where she gained a First Class Honours degree and Imperial College. She trained in Haematology in University College London Hospital before undertaking research in epigenetic related prognostic factors in acute myeloid leukaemia at UCL Cancer Institute. 

Dr El-Sharkawi won the EHA Clinical Research Fellowship in 2017. Her special interests are in CLL, rare leukaemias and lymphomas as well as early phase trials and drug development. She has been an investigator on a number of clinical research studies in these disease groups. She is also part of the haematological malignancy diagnostic services at the Royal Marsden.

Past attendee feedback

Held as an interactive online forum, here is some feedback on the excellent content from the professionals who attended:

‘Very interactive. Easier to focus on a short 3.5hr event, then a whole date.’

The Royal Marsden NHS Foundation Trust

‘All the presentations were excellent - learnt so much.’

The Harbour Hospital, Circle Health group

‘Loved the slides of Sarah Henshaw, very informative. The management of haem emergencies was very interesting.'

The Royal Marsden NHS Foundation Trust

‘I enjoyed interactive discussion because ideas of practice was shared.'

Barnet and Chase Farm hospital

‘Excellent, very informative and tech support fab.’

Hywel Dda University Health Board

‘Absolutely brilliant webinar thank you very much. I like the interactive part, I enjoyed all of the speakers, especially as they spoke at a level we could all understand. Thank you.’

Maidstone NHS Trust

Who came?

The following is an insight into the job titles and organisations who came to the Latest Developments and Clinical Updates for Haemato-Oncology forum when it was held on Thursday 17th March 2022.


Job titles: 

  • Senior Oncology Clinical Trial Research Nurse
  • Acute Oncology ACP 
  • Acute Oncology CNS 
  • Advanced Nurse Practioner 
  • Clinical Engagement Manager 
  • Clinical Lead 
  • Clinical Services Manager Oncology 
  • Clinical Trial Co-ordinator 
  • Community Nurse 
  • Consultant 
  • Consultant Haematologist 
  • Consultant Haematology 
  • Haematology & Clinical Trials Pharmacist 
  • Haematology CNS 
  • Haematology Nurse Practitioner 
  • Haematology Pharmacist 
  • Haematology Research Nurse 
  • Haematology/Oncology Nurse 
  • Haemato-Oncology Outpatients Manager 
  • Immunotherapy CNS 
  • Junior Doctor, Haematology 
  • Lead Chemotherapy Nurse 
  • Lead Clinical Trials Pharmacist 
  • Macmillan Acute Oncology Clinical Nurse Specialist Macmillan Haematology Support
  • Myeloma CNS
  • Nurse 
  • Nurse Consultant
  • Nurse Specialist 
  • Research Nurse, Haematology 
  • RGN 
  • Senior Oncology Nurse 
  • Senior Research Nurse 
  • Senior Sister 
  • Senior Staff Nurse 
  • Staff Nurse 
  • Student Nurse 
  • Trainee Advanced Clinical Practitioner 
  • Ward Sister

Organisations: 

  • The Princess Alexandra Hospital 
  • Barking Havering Redbridge University Trust 
  • Basingstoke & North Hampshire Hospital Trust 
  • Birmingham West and Sandwell NHS Trust 
  • Blood Cancer UK 
  • BMI Healthcare, Circle Health Group 
  • Buckinghamshire Healthcare 
  • Central North West London Community Trust 
  • Circle Health Group 
  • Clatterbridge Cancer Centre 
  • Darent Valley Hospital 
  • Doncaster & Bassetlaw NHS Trust 
  • Dorset County Hospital 
  • East Lancashire Hospitals Trust 
  • ELHT, Royal Blackburn Hospital 
  • Hywel Dda Health Board 
  • Imperial College Healthcare 
  • James Cook University Hospital 
  • London South Bank 
  • Luton & Dunstable University Hospital 
  • Maidstone Hospital 
  • Maidstone NHS Trust 
  • Medway NHS Foundation Trust 
  • Mid & South Essex NHS Trust 
  • Midlands Partnership NHS Foundation Trust 
  • Newcastle Upon Tyne NHS Trust 
  • Northampton General Hospital 
  • Royal Cornwall Hospital Trust 
  • Royal Devon & Exeter NHS Foundation Trust 
  • Royal Free Hospital 
  • Royal Marsden NHS Foundation Trust, Sutton Branch 
  • Sandwell & West Birmingham NHS Trust 
  • Shrewsbury & Telford NHS Hospital Trust 
  • Southport and Ormskirk NHS Trust 
  • Stepping Hill Hospital 
  • The Dudley Group NHS Foundation Trust, Russells Hall Hospital 
  • The London Clinic 
  • The Queen Elizabeth Hospital, Kings Lynn 
  • The Royal Marsden NHS Foundation Trust 
  • University College London NHS Foundation Trust 
  • Worcestershire Acute Hospitals NHS Trust